Spectral AI, Inc.

Spectral AI, Inc. announced the results of its 2026 Annual Meeting of Stockholders, where all three proposals were approved. Stockholders elected five directors, ratified Forvis Mazars LLP as the independent auditor, and authorized the issuance of shares to Hudson Bay Master Fund Ltd. The company also provided a business update, highlighting the recent FDA De Novo Classification for its DeepView System for Burn Indication, which enables commercial distribution in the U.S. Spectral AI outlined key operational achievements, including $31.7 million in BARDA funding, and anticipates generating first commercial sales by year-end 2026.

Spectral AI, Inc. announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView System. This classification authorizes the company to commence commercial distribution activities in the United States for its AI-powered medical device. The DeepView System is designed for burn care, providing a rapid, non-invasive assessment of burn wound healing potential to aid in treatment decisions.

Spectral AI announced that its DeepView System received De Novo Classification from the U.S. FDA, authorizing commercial distribution in the United States. This AI-powered medical device provides a non-invasive, predictive assessment of burn wound healing potential, enabling faster and more accurate treatment decisions. The company believes this milestone will redefine burn wound care, improve patient outcomes, and enhance cost efficiency.

Spectral AI, Inc. reported a net loss of $(3.41) million for the first quarter of 2026, a significant decline from a net income of $2.90 million in the prior year period. Research and development revenue decreased by 40.5% to $3.99 million. Despite the financial downturn, the company received a contract modification from BARDA, accelerating $31.7 million in funding and extending the base phase of its existing contract, which has an overall value of up to $150 million. The company's cash balance decreased to $11.66 million as of March 31, 2026.

Spectral AI, Inc. announced its first quarter 2026 financial results, reporting a net loss of $(3.4) million, or $(0.11) per diluted share, compared to a net income of $2.9 million in the prior year. Research & Development revenue decreased to $4.0 million from $6.7 million, reflecting an anticipated decline in work under the base phase of the Project BioShield contract. The company highlighted continued development of its DeepView System, supported by a recently awarded $31.7 million in advanced, non-dilutive funding from BARDA for an accelerated second phase of the contract, and reiterated its 2026 annual revenue guidance of approximately $18.5 million.

Spectral AI, Inc. has finalized an employment agreement with Vincent S. Capone, confirming his role as Chief Executive Officer. The agreement, effective April 17, 2026, outlines an annual base compensation of $500,000 and eligibility for an annual target bonus of up to 100% of his base salary, with a minimum of $250,000. Mr. Capone will also receive a grant of 200,000 restricted stock units (RSUs), vesting 50% on April 1, 2026, and the remaining 50% on April 1, 2027, with full vesting upon a change of control.

Spectral AI, Inc. announced its 2026 Annual Meeting of Stockholders will be held on Friday, May 29, 2026, at 9:30 a.m. Central Daylight Time. Stockholders of record as of April 1, 2026, are eligible to vote and can attend either in person or virtually. Important information regarding the meeting is available in the Definitive Proxy Statement filed with the SEC on April 16, 2026.

Spectral AI, Inc. has announced the appointment of David McGuire as its new Chief Financial Officer, effective May 4, 2026. Mr. McGuire brings over two decades of extensive experience in finance and accounting, including significant expertise in financial reporting, investor relations, and capital markets activities for publicly traded companies. His background, which includes roles at Solo Brands, Inc. and EZCORP, Inc., suggests a strategic move by Spectral AI to bolster its financial leadership and operational controls. This appointment is expected to strengthen the company's capabilities in financial management, compliance, and strategic growth initiatives.